Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Formin-1 (FMN1) is a member of the formin family of proteins, which are highly conserved actin nucleating and organizing factors essential for defining cell shape, polarity, migration, and division[1][3][4][6]. Formin-1 is characterized by formin homology domains (FH1 and FH2) that mediate its ability to nucleate and elongate unbranched actin filaments. The FH2 domain specifically encircles the barbed (fast-growing) end of actin filaments, promoting polymerization while protecting filaments from capping proteins[4][5][6]. FMN1 also acts as a scaffold, interacting with proteins like profilin and α-catenin to coordinate cytoskeletal and cell adhesion networks[3]. In mouse, Fmn1 is essential for limb and kidney morphogenesis, and mutations lead to the \"limb deformity\" phenotype. FMN1 is encoded on human chromosome 15q13.3[3]. Although not a classical drug target or receptor, FMN1 is a critical mediator of cellular architecture and motility, with developmental roles supported by both animal and human data[1][3]. There are currently no known drugs directly targeting FMN1, and its therapeutic tractability remains largely unexplored.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Formin-1 (FMN1).